methacetin has been researched along with Liver Neoplasms in 10 studies
methacetin: RN given refers to parent cpd
methacetin : A member of the class of acetamides that is paracetamol in which the hydrogen of phenolic hydroxy group has been replaced by a methyl group.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methacetin metabolism was significantly decreased following TACE (-28%, P < 0." | 2.74 | Liver function as assessed by breath tests in patients with hepatocellular carcinoma. ( Grattagliano, I; Minerva, F; Palasciano, G; Palmieri, VO; Pollice, S; Portincasa, P, 2009) |
| "Thirty-nine patients with primary liver cancer, 16 patients with hepatic metastasis and 14 healthy volunteers serving as controls were included in this study." | 2.74 | [The value of studying liver function reserve in hepatic carcinoma by 13C-methacetin breath test]. ( Feng, QL; Li, HX; Wang, JP; Yang, Y; Zhang, J, 2009) |
| "20 patients with intermediate-stage hepatocellular carcinoma (HCC) received a LiMAx test 24 h pre and post TACE." | 1.62 | Prediction of transarterial chemoembolization (TACE) outcome by pre- and postinterventional 13C-methacetin breath test. ( Bäumler, W; Haimerl, M; Rio Bartulos, C; Senk, K; Stroszczynski, C; Verloh, N; Wiggermann, P; Wilcke, J, 2021) |
| "Liver failure has remained a major cause of mortality after hepatectomy, but it is difficult to predict preoperatively." | 1.36 | The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. ( Lock, JF; Malinowski, M; Neuhaus, P; Niehues, SM; Seehofer, D; Stockmann, M, 2010) |
| "Liver failure is a major cause of mortality after hepatectomy." | 1.35 | Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. ( Fricke, M; Heyne, K; Lehmann, S; Lemke, AJ; Lock, JF; Martus, P; Neuhaus, P; Niehues, SM; Riecke, B; Schwabe, M; Stockmann, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Senk, K | 1 |
| Wilcke, J | 1 |
| Haimerl, M | 1 |
| Verloh, N | 1 |
| Rio Bartulos, C | 1 |
| Bäumler, W | 1 |
| Stroszczynski, C | 1 |
| Wiggermann, P | 1 |
| Gairing, SJ | 1 |
| Kuchen, R | 1 |
| Müller, L | 1 |
| Cankaya, A | 1 |
| Weerts, J | 1 |
| Kapucu, A | 1 |
| Sachse, S | 1 |
| Zimpel, C | 1 |
| Stoehr, F | 1 |
| Pitton, MB | 1 |
| Mittler, J | 1 |
| Straub, BK | 1 |
| Marquardt, JU | 1 |
| Schattenberg, JM | 1 |
| Labenz, C | 1 |
| Kloeckner, R | 1 |
| Weinmann, A | 1 |
| Galle, PR | 1 |
| Wörns, MA | 1 |
| Foerster, F | 1 |
| Lock, JF | 5 |
| Westphal, T | 1 |
| Rubin, T | 1 |
| Malinowski, M | 4 |
| Schulz, A | 2 |
| Jara, M | 3 |
| Bednarsch, J | 3 |
| Stockmann, M | 5 |
| Seehofer, D | 2 |
| Pratschke, J | 1 |
| Palmieri, VO | 1 |
| Grattagliano, I | 1 |
| Minerva, F | 1 |
| Pollice, S | 1 |
| Palasciano, G | 1 |
| Portincasa, P | 1 |
| Riecke, B | 1 |
| Heyne, K | 1 |
| Martus, P | 1 |
| Fricke, M | 1 |
| Lehmann, S | 1 |
| Niehues, SM | 2 |
| Schwabe, M | 1 |
| Lemke, AJ | 1 |
| Neuhaus, P | 2 |
| Li, HX | 1 |
| Wang, JP | 1 |
| Yang, Y | 1 |
| Zhang, J | 1 |
| Feng, QL | 1 |
| Matsumoto, K | 1 |
| Suehiro, M | 1 |
| Iio, M | 1 |
| Kawabe, T | 1 |
| Shiratori, Y | 1 |
| Okano, K | 1 |
| Sugimoto, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development of a Breath Test for Monitoring Liver Metabolic Function in Patients With Chronic Liver Disease and Cirrhosis[NCT00244569] | Phase 3 | 120 participants (Anticipated) | Interventional | 2005-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for methacetin and Liver Neoplasms
| Article | Year |
|---|---|
[Enhancing safety in liver surgery using a new diagnostic tool for evaluation of actual liver function capacity - The LiMAx test].
Topics: Acetamides; Breath Tests; Cause of Death; Hepatectomy; Humans; Liver Diseases; Liver Failure; Liver | 2014 |
Noninvasive diagnosis of chemotherapy induced liver injury by LiMAx test--two case reports and a review of the literature.
Topics: Acetamides; Aged; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Diagnostic Techniqu | 2015 |
2 trials available for methacetin and Liver Neoplasms
| Article | Year |
|---|---|
Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Breath Tests; Carbon Isotopes; Carcinoma, Hepatocellular | 2009 |
[The value of studying liver function reserve in hepatic carcinoma by 13C-methacetin breath test].
Topics: Acetamides; Aged; Aged, 80 and over; Breath Tests; Carcinoma, Hepatocellular; Case-Control Studies; | 2009 |
6 other studies available for methacetin and Liver Neoplasms
| Article | Year |
|---|---|
Prediction of transarterial chemoembolization (TACE) outcome by pre- and postinterventional 13C-methacetin breath test.
Topics: Acetamides; Breath Tests; Carbon Isotopes; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic | 2021 |
13 C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Topics: Albumins; Bilirubin; Breath Tests; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; End St | 2022 |
LiMAx Test Improves Diagnosis of Chemotherapy-Associated Liver Injury Before Resection of Colorectal Liver Metastases.
Topics: Acetamides; Aged; Algorithms; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Chemoth | 2017 |
Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity.
Topics: Acetamides; Aged; Breath Tests; Female; Hepatectomy; Humans; Indicators and Reagents; Liver; Liver F | 2009 |
The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery.
Topics: Acetamides; Aged; Algorithms; Breath Tests; Carbon Isotopes; Decision Trees; Female; Hepatectomy; Ho | 2010 |
[13C]methacetin breath test for evaluation of liver damage.
Topics: Acetamides; Adult; Breath Tests; Carbon Dioxide; Carcinoma, Hepatocellular; Female; Humans; Liver Ci | 1987 |